peplexicon
Choose your depth

Context, anatomy, and key evidence

← Peptide library

myostatin inhibitor (ActRIIB)

ACE-031

Published evidence · coverage incomplete

Anatomy in the research

Anatomy evidence is still being assembled.

These are anatomical mentions in cited research—not established treatment targets or proof of benefit in people.

This publication has no anatomy passages that meet our source-linking checks yet. Read the available findings ↓

General anatomy view only. No peptide-specific structures are highlighted.

At a glance

What is it—and why does it matter?

An introduction is not yet available. The findings below address specific research questions, not a complete account of this peptide.

This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.

What is it?

A molecule, not a product name.

Identity

In testing black-market products marketed as ACE-031, 12 of 14 showed ACVR2B immunoreactivity, indicating presence of an ACVR2B-reactive protein.

Sources[1]doiGel Electrophoretic Detection of Black Market ACE‐031Of 14 tested products, only 12 contained an ACVR2B‐immunoreactive protein.
Reported result
12 of 14 products
Source records
1
Independent studies
1

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    “Of 14 tested products, only 12 contained an ACVR2B‐immunoreactive protein.”

    Gel Electrophoretic Detection of Black Market ACE‐031 · Abstract

    doi:10.1002/dta.3898:9a9de16f6362:9a9de16f6362

How does it work?

Target, response, and disposition.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

What has been studied?

What the evidence says.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Risks and interactions

Risks, organized for scanning.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Products and regulatory status

Same ingredient. Different records.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Administration context

The practical clinical context.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Research status + gaps

What still needs better answers?

  • No publishable claim yet for: administration, contraindication, effect, interaction, mechanism, regulatory, safety
  • 54 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (30), assurance_score_below_0.72 (22), current_regulatory_source_required (7), extraction_ambiguity (43), high_risk_requires_regulatory_or_two_independent_sources (23), no_direct_support (50), proposal_not_staged (1)
  • A source-backed introductory overview is not yet available.

These are the limits of this profile, not an exhaustive list of scientific uncertainties.

References + discovery

Open the records yourself.

  1. Gel Electrophoretic Detection of Black Market ACE‐031 ↗

    doi · published 2025-05-01 · retrieved 2026-09-04T19:08:23Z

Publication history and provenance

Version 1 · Automated assessment · 2026-09-04T19:08:23Z

8231100f60f95910de28eeceb111001839388898e11bc4648269ca097a8c3b3f